A detailed history of Hancock Whitney Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Hancock Whitney Corp holds 4,676 shares of BDX stock, worth $1.04 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,676
Previous 4,743 1.41%
Holding current value
$1.04 Million
Previous $1.11 Million 1.71%
% of portfolio
0.04%
Previous 0.04%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$221.47 - $242.41 $14,838 - $16,241
-67 Reduced 1.41%
4,676 $1.13 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $23,857 - $26,094
-106 Reduced 2.19%
4,743 $1.11 Million
Q1 2024

May 16, 2024

BUY
$233.45 - $247.73 $13,306 - $14,120
57 Added 1.19%
4,849 $1.2 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $25,314 - $29,128
-109 Reduced 2.22%
4,792 $1.17 Million
Q3 2023

Nov 13, 2023

SELL
$254.9 - $283.59 $84,881 - $94,435
-333 Reduced 6.36%
4,901 $1.27 Million
Q2 2023

Nov 13, 2023

SELL
$238.39 - $265.32 $19,309 - $21,490
-81 Reduced 1.52%
5,234 $1.38 Million
Q2 2023

Aug 10, 2023

SELL
$238.39 - $265.32 $19,309 - $21,490
-81 Reduced 1.52%
5,234 $1.38 Million
Q1 2023

Nov 13, 2023

SELL
$229.71 - $259.35 $1,837 - $2,074
-8 Reduced 0.15%
5,315 $1.32 Million
Q1 2023

May 16, 2023

SELL
$229.71 - $259.35 $1,837 - $2,074
-8 Reduced 0.15%
5,315 $1.32 Million
Q4 2022

Nov 13, 2023

BUY
$218.29 - $256.91 $19,427 - $22,864
89 Added 1.7%
5,323 $1.35 Million
Q4 2022

Feb 03, 2023

SELL
$218.29 - $256.91 $1,091 - $1,284
-5 Reduced 0.09%
5,323 $1.35 Million
Q3 2022

Oct 26, 2022

SELL
$51.03 - $264.23 $4,745 - $24,573
-93 Reduced 1.72%
5,328 $1.19 Million
Q2 2022

Aug 08, 2022

SELL
$234.74 - $275.42 $44,131 - $51,778
-188 Reduced 3.35%
5,421 $1.34 Million
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $30,455 - $33,810
-125 Reduced 2.18%
5,609 $1.49 Million
Q4 2021

Jan 25, 2022

SELL
$230.08 - $250.94 $46,246 - $50,438
-201 Reduced 3.39%
5,734 $1.44 Million
Q3 2021

Nov 04, 2021

SELL
$232.72 - $256.47 $32,580 - $35,905
-140 Reduced 2.3%
5,935 $1.46 Million
Q2 2021

Aug 09, 2021

BUY
$232.65 - $254.58 $3,722 - $4,073
16 Added 0.26%
6,075 $1.48 Million
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $15,782 - $17,467
-68 Reduced 1.11%
6,059 $1.47 Million
Q4 2020

Feb 09, 2021

SELL
$221.92 - $245.94 $46,159 - $51,155
-208 Reduced 3.28%
6,127 $1.53 Million
Q3 2020

Nov 05, 2020

SELL
$215.77 - $276.76 $6,257 - $8,026
-29 Reduced 0.46%
6,335 $1.47 Million
Q2 2020

Jul 30, 2020

SELL
$219.9 - $263.41 $152,830 - $183,069
-695 Reduced 9.85%
6,364 $1.52 Million
Q1 2020

May 08, 2020

SELL
$195.69 - $279.01 $500,966 - $714,265
-2,560 Reduced 26.61%
7,059 $1.62 Million
Q4 2019

Feb 06, 2020

SELL
$236.45 - $266.82 $4.23 Million - $4.77 Million
-17,882 Reduced 65.02%
9,619 $2.62 Million
Q3 2019

Oct 29, 2019

SELL
$230.58 - $256.08 $244,414 - $271,444
-1,060 Reduced 3.71%
27,501 $6.96 Million
Q2 2019

Aug 29, 2019

SELL
$217.4 - $246.08 $72,394 - $81,944
-333 Reduced 1.15%
28,561 $7.2 Million
Q1 2019

May 13, 2019

SELL
$206.05 - $248.17 $98,697 - $118,873
-479 Reduced 1.63%
28,894 $7.22 Million
Q4 2018

Feb 15, 2019

SELL
$204.73 - $257.93 $281,708 - $354,911
-1,376 Reduced 4.47%
29,373 $6.62 Million
Q3 2018

Nov 14, 2018

BUY
$233.07 - $256.0 $6.34 Million - $6.96 Million
27,186 Added 763.01%
30,749 $8.03 Million
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $12.2 Million - $13.7 Million
-58,702 Reduced 94.28%
3,563 $854,000
Q1 2018

May 15, 2018

SELL
$205.46 - $240.27 $517,759 - $605,480
-2,520 Reduced 3.89%
62,265 $13.5 Million
Q4 2017

Feb 12, 2018

SELL
$189.0 - $222.64 $628,803 - $740,723
-3,327 Reduced 4.88%
64,785 $13.9 Million
Q3 2017

Nov 14, 2017

SELL
$186.89 - $198.9 $712,424 - $758,206
-3,812 Reduced 5.3%
68,112 $13.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
71,924
71,924 $14 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Hancock Whitney Corp Portfolio

Follow Hancock Whitney Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hancock Whitney Corp with notifications on news.